Results 101 to 110 of about 3,922 (162)

Association between treatment with sacubitril/valsartan and the risk of Alzheimer's disease: a clinical update. [PDF]

Alzheimers Res Ther
Garnier-Crussard A.
europepmc   +1 more source

Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure. [PDF]

Open Heart
Neijenhuis RML, Nederend M, van Groningen AE, Jongbloed MRM, Vliegen HW, Jukema JW, Kiès P, Egorova AD.   +7 more
europepmc   +1 more source

Memory impairment with symmetrical hippocampal lesions following acute glufosinate-ammonium intoxication. [PDF]

BMJ Case Rep
Antunes D, Pereira DJ, Brás P, Jesus-Ribeiro J.   +3 more
europepmc   +1 more source

Pharmacogenetic Influences Over Mavacamten Pharmacokinetics: Considerations for the Treatment of Individuals With Hypertrophic Cardiomyopathy. [PDF]

Circulation
McGurk KA, Bilgehan N, Ware JS.
europepmc   +1 more source

Impact of treatment strategies incorporating sacubitril/valsartan on achievement of guideline-recommended blood pressure targets and representative safety outcomes. [PDF]

Hypertens Res
Katsuya T, Nakatsu F, Eguchi S, Nakamura Y, Matsukawa M, Iekushi K, Hiramitsu S.   +6 more
europepmc   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK-3β Axis. [PDF]

Kaohsiung J Med Sci
Yang YJ, Li JS.
europepmc   +1 more source

Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease. [PDF]

J Clin Hypertens (Greenwich)
Murakoshi M, Kobayashi T, Kihara M, Ueda S, Suzuki Y, Gohda T.   +5 more
europepmc   +1 more source

The SARAH trial: more evidence on the role of neurohormonal blockers in prevention of anthracycline-induced cardiotoxicity. [PDF]

Heart Fail Rev
Mecinaj A, Vinje-Jakobsen V, Ngo DTM, Sverdlov AL, Myhre PL.   +4 more
europepmc   +1 more source

Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction. [PDF]

Am J Physiol Heart Circ Physiol
Clemmer JS, Hall ME, Mallette JH, Pruett WA.   +3 more
europepmc   +1 more source

Bilateral renal artery revascularisation in heart failure. [PDF]

BMJ Case Rep
Quilty F, Abel AAI, Clark AL.
europepmc   +1 more source